Researchers at City of Hope have developed a small molecule called AOH1996 that targets a specific protein variant essential for cancer cell DNA replication. The drug has shown the ability…
Researchers have identified a potent anti-cancer compound, Salinosporamide A, derived from the deep-sea bacterium Salinispora tropica. Clinical trials at major medical centers are currently evaluating its efficacy in treating glioblastoma,…
A collaborative study between Roche and Harvard University has led to the discovery of Zosurabalpin, a new antibiotic class that effectively kills carbapenem-resistant Acinetobacter baumannii. The drug works by inhibiting…
Google DeepMind has introduced AlphaProteo, an AI system capable of designing novel proteins that bind to specific target molecules with high affinity. This breakthrough significantly accelerates the development of new…
Insilico Medicine has advanced the first generative AI-discovered and AI-designed drug candidate into Phase II clinical trials. The drug, INS018_055, targets idiopathic pulmonary fibrosis, a chronic condition that causes progressive…
Scientists on an Arctic expedition have discovered a novel antibiotic compound produced by deep-sea actinobacteria. This molecule effectively inhibits the virulence of Gram-negative bacteria like E. coli without damaging human…
Vertex Pharmaceuticals has successfully completed Phase 3 trials for suzetrigine, a novel non-opioid pain medication. By targeting specific sodium channels in the peripheral nervous system, the drug blocks pain signals…
Researchers have utilized explainable deep learning to discover a new class of antibiotics capable of killing methicillin-resistant Staphylococcus aureus (MRSA). This breakthrough marks one of the first times AI has…
Scientists have identified a new antibiotic called Clovibactin, isolated from previously unculturable soil bacteria using innovative iCHIP technology. This compound employs a unique mechanism to destroy drug-resistant pathogens by binding…
